Home › Funds › Kiltearn Partners LLP › SOLV

Kiltearn Partners LLP position in SOLV

SOLVENTUM CORP · Health Care

Kiltearn Partners LLP reported holding 93,210 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$8.2M, representing 1.98% of its reported portfolio and ranking #19 among its reported holdings. Kiltearn Partners LLP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)93.21K sh
Reported value held$8.22M
Portfolio Weight1.98%
First reportedQ3 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Kiltearn Partners LLP's SOLV position evolved

Kiltearn Partners LLP first disclosed a stake in SOLV in Q3 2024 at 40,700 shares (US$2.8M). The position peaked in Q3 2026 at 93,210 shares, worth US$8.2M. Across 9 filings, Kiltearn Partners LLP increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,210 shares valued at US$8.2M — a reduction of -4,193 shares quarter over quarter.. Notable position changes include a 81% increase in Q4 2024 (shares rose 15% over the following quarter), a 37% increase in Q1 2025 (shares were roughly flat over the following quarter), a 30% increase in Q1 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 40.70K $2.84M New
Q4 2024 73.50K $4.86M Add
Q1 2025 100.60K $7.65M Add
Q2 2025 99.50K $7.55M Reduce
Q3 2025 93.00K $6.79M Reduce
Q4 2025 78.91K $6.25M Reduce
Q1 2026 102.30K $6.68M Add
Q2 2026 97.40K $7.51M Reduce
Q3 2026 93.21K $8.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has Kiltearn Partners LLP held SOLV?

Kiltearn Partners LLP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Kiltearn Partners LLP's current position in SOLV?

As of Q3 2026, Kiltearn Partners LLP holds 93.21K shares of SOLV (SOLVENTUM CORP), valued at $8.22M, representing 1.98% of its reported portfolio and ranking #19.

Has Kiltearn Partners LLP been buying or selling SOLV?

In the latest 13F filing (Q3 2026), Kiltearn Partners LLP reduced its position in SOLV. The position peaked in Q3 2026 at 93.21K shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.